메뉴 건너뛰기




Volumn 12, Issue 3, 2005, Pages 357-374

NF-κB in human disease: Current inhibitors and prospects for De Novo structure based design of inhibitors

Author keywords

Cancer; De novo design; Degradation; DNA binding; Inflammatory diseases; I B; I B kinases; NF B; Oxidative stress; Phosphorylation; Viral diseases

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANGIOTENSIN; ANTITHROMBIN III; ARSENOSOBENZENE; BORTEZOMIB; CAFFEIC ACID; CURCUMIN; DIHYDROLIPOATE; EPOXOMICIN; GINSENOSIDE; I KAPPA B; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LACIDIPINE; LACTACYSTIN; LATENT MEMBRANE PROTEIN 1; PROTEASOME INHIBITOR; PROTEIN BCL 3; QUERCETIN; S ALLYLCYSTEINE; SALAZOSULFAPYRIDINE; TEPOXALIN; THALIDOMIDE; THIOCTIC ACID; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; UNINDEXED DRUG; ANTIOXIDANT; ATP DEPENDENT 26S PROTEASE; PROTEASOME;

EID: 14544269951     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/0929867053363180     Document Type: Review
Times cited : (125)

References (392)
  • 13
  • 108


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.